MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Dopamine agonist withdrawal syndrome (DAWS) in a tertiary Parkinson’s disease center

    S. Patel, X. Garcia, M.E. Mohammad, X.X. Yu, K. Vlastaris, K. O'Donnell, K. Sutton, H.H. Fernandez (Cleveland, OH, USA)

    Objective: To describe the frequency, characteristics and potential risk factors for Dopamine Agonist Withdrawal Syndrome (DAWS). Background: Dopamine agonists are a mainstay of treatment for…
  • 2016 International Congress

    The effect of levodopa-carbidopa intestinal gel on activities of daily living: Results from the observational MONOTREAT study in advanced Parkinson’s disease patients

    R. Krüger, P. Lingor, T. Doskas, J. Henselmans, E.H. Danielsen, O. de Fabregues, A. Stefani, S.C. Sensken, J.C. Parra Riaza, K. Onuk, A. Yegin (Tübingen, Germany)

    Objective: To assess the tolerability and effect of levodopa-carbidopa intestinal gel (LCIG, designated in the United States as carbidopa-levodopa enteral suspension) on activities of daily…
  • 2016 International Congress

    Conversion of patients from immediate release carbidopa-levodopa (IR CD-LD) and sustained release carbidopa-levodopa (SR CD-LD) to extended-release carbidopa-levodopa (ER CD-LD) in clinical practice

    S.J. LoRusso, B. Ouyang, B.R. Barton (Chicago, IL, USA)

    Objective: To evaluate the real-world response of patients who are converted from IR CD-LD and SR CD-LD to ER CD-LD in an academic practice. Background:…
  • 2016 International Congress

    Fox insight wear ecosystem: using mobile technology and cloud-based computing to support PD research

    I. Feldman, M. Afek, L. Bataille (Gedera, Israel)

    Objective: To enable a simple strategy for the continuous collection and analysis of sensory data from Parkinson's disease (PD) patients that can increase the effectiveness…
  • 2016 International Congress

    Evaluation of droxidopa dosing and clinical response in 50 consecutive patients with Parkinson’s disease and symptomatic neurogenic orthostatic hypotension

    S.H. Isaacson, S. Brillman, N. Chhabria (Boca Raton, FL, USA)

    Objective: To determine the effect of droxidopa on clinical symptoms and standing systolic blood pressure in patients with Parkinson's disease (PD) and neurogenic orthostatic hypotention…
  • 2016 International Congress

    Efficiency of carotid endarterectomy in vascular parkinsonism in patients with stenotic carotid artery disease

    M. Ataniyazov, G. Rakhimbaeva, K. Ataniyazova (Tashkent, Uzbekistan)

    Objective: Primary aim of investigation was to evaluate the effectiveness of carotid endarterectomy (CEA) in patients with vascular parkinsonism (VP) with stenotic lesions of carotid…
  • 2016 International Congress

    Transcranial versus root repeated magnetic stimulation as a treatment of psychogenic movement disorders

    B. Garcin, C. Hubsch, L. Lliescu, L. Naccache, M. Vidailhet, E. Fournier, F. Mesrati, E. Roze, B. Degos (Paris, France)

    Objective: To determine whether the beneficial effect of repeated transcranial magnetic stimulation (rTMS) in psychogenic movement disorders (PMDs) is the consequence of a cortical functioning…
  • 2016 International Congress

    Significant improvement of adult-onset dystonia with cannabinoids-based oromucosal spray

    M. Aguilar, S. Romero, L. Molina Porcel, P. Pastor (Terrassa, Spain)

    Objective: We performed an open study of delta-9-tetrahydrocannabinol and cannabidiol (THC:CBD) oromucosal spray (Nabiximols, Sativex®) in 6 patients with suboptimal responsive adult-onset dystonia. Background: Cannabinoids…
  • 2016 International Congress

    Can intraoperative clinical testing really predict the effects of deep brain stimulation in the subthalamic nucleus?

    J. Blume, J. Schlaier, F. Zeman, E. Rothenfußer, A. Brawanski, U. Bogdahn, M. Lange (Regensburg, Germany)

    Objective: To evaluate whether stimulation-induced therapeutic and side effects of the permanent electrode are predictable by intraoperative test stimulation with clinical examination. Background: Intraoperative test…
  • 2016 International Congress

    Multiple-source current steering in bilateral subthalamic nucleus deep brain stimulation for Parkinson’s disease: Our experience

    J.M. Cardenas Prieto, P.A. Millan Giraldo (Cali, Colombia)

    Objective: To evaluate the efficacy and side effects of a multiple-source, constant-current device in a Latin-American population of patients with PD. Background: Timmermann et al.…
  • « Previous Page
  • 1
  • …
  • 76
  • 77
  • 78
  • 79
  • 80
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An atypical and interesting feature of Parkinson´s disease
  • #25136 (not found)
  • Unusual prolonged survival in multiple system atrophy: A case report
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley